Professor of Medicine and a Scientist with the Broad Stem Cell Research Center, UCLA
Professor of Medicine and a Scientist with the Broad Stem Cell Research Center, UCLA
PROFILE
Dr. Antoni Ribas
Guest
FROM Dr. Antoni Ribas
Which Way, L.A.?
Big Stem Cell Grants California’s Institute for Regenerative Medicine is a unique state agency—with guaranteed funding of 3 billion dollars from bonds. It was created by the voters in 2004, when the Bush Administration opposed using embryonic stem cells for medical research. The promise was to develop treatments for incurable diseases but—whatever the voters thought 8 years ago—that takes a long time. Last week, the Institute passed out its latest grants—150 million dollars, in hopes of moving from laboratories into clinical trials. UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research got 20 million dollars last week from the Institute.
Recommended
Left, Right & Center
President Trump: US to withdraw from the Paris Climate Accord Trump says he was elected to serve Pittsburgh, not Paris.
To the Point
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
To the Point
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
To the Point
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.